The use of G-CSF has been associated with reactivation of rheumatoid arthritis [12], as well as associated with flare or increased activity of the primary autoimmune disease prior to bone marrow transplant for such patients [13]. The gene discussed is CSF3; the disease is rheumatoid arthritis.